• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Psoriasis Foundation awards $480,000 in fellowships

Psoriasis Foundation awards $480,000 in fellowships

July 6, 2011
CenterWatch Staff

The National Psoriasis Foundation awarded $480,000 in research fellowships to 12 early-career doctors, who each received a one-year, $40,000 fellowship to study psoriasis and psoriatic arthritis.

The grants are intended to increase activity in psoriatic disease research leading to better treatments and a cure for psoriasis and psoriatic arthritis.The fellowships team a doctor with an established psoriatic disease investigator who will supervise the fellow's work.

The 2011 National Psoriasis Foundation Fellows and their projects are:

  • Maryam Afshar, MBBS, of the University of California, San Diego School of Medicine, will focus on the immune system in people with psoriasis during hepatitis C infection.
  • Shiu-chang Au, M.D., of Tufts Medical School in Boston, will examine whether children with psoriatic disease have a higher rate of metabolic syndrome and cardiovascular risk factors.
  • Elizabeth Chase, M.D., of the University of California, Davis, will study psoriasis and its connection to a higher rate of cardiovascular diseases.
  • Madeline Haddican, M.D., of Mount Sinai School of Medicine in New York City, will focus on psoriasis clinical trials.
  • Faiyaaz A. Kalimullah, M.D., of Wake Forest University School of Medicine in Winston-Salem, N.C., will investigate adherence to treatment, cost effectiveness of treatment and new protocols for phototherapy, a therapy which exposes the skin to ultra-violet light.
  • Douglas Kast, D.O., of Case Western Reserve University and University Hospitals in Cleveland, Ohio, will research cardiovascular risk in psoriasis using the CACS score, a special X-ray test that detects early stage heart disease.
  • Peter Mattei, M.D., of Harvard Medical School in Boston, will develop a set of standardized outcome measures in clinical practice.
  • Katherine M. Mercy, M.D., of The Feinberg School of Medicine at Northwestern University in Evanston, Ill., will identify the relationship between body mass index and psoriasis in children.
  • Amilcar Rizzo, M.D., of Stanford University School of Medicine in Palo Alto, Calif., will try to understand the skin's immune interactions in psoriasis.
  • Bryan Sofen, M.D., of New York University in New York City, will explore the cutaneous microbiome, the population of microorganisms that live on the skin, in people with psoriasis to try and determine whether these organisms play a role in the disease.
  • Junko Takeshita, M.D., of the University of Pennsylvania in Philadelphia, will examine cardiovascular risk in psoriasis and the effectiveness of therapies.
  • Daniel Zaghi, M.D., of the University of Utah in Salt Lake City, will investigate if smoking affects the development of psoriasis and psoriatic arthritis.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing